Increased bone formation in mice lacking plasminogen activators
- PMID: 12854826
- DOI: 10.1359/jbmr.2003.18.7.1167
Increased bone formation in mice lacking plasminogen activators
Abstract
Plasminogen activators tPA and uPA are involved in tissue remodeling, but their role in bone growth is undefined. Mice lacking tPA and uPA show increased bone formation and bone mass. The noncollagenous components of bone matrix are also increased, probably from defective degradation. This study underlines the importance of controlled bone matrix remodeling for normal endochondral ossification.
Introduction: Proteolytic pathways are suggested to play a role in endochondral ossification. To elucidate the involvement of the plasminogen activators tPA and uPA in this process, we characterized the long bone phenotype in mice deficient in both tPA and uPA (tPA-/-:uPA-/-).
Materials and methods: Bones of 2- to 7-day-old tPA-/-:uPA-/- and wild-type (WT) mice were studied using bone histomorphometry, electron microscopy analysis, and biochemical assessment of bone matrix components. Cell-mediated degradation of metabolically labeled bone matrix, osteoblast proliferation, and osteoblast differentiation, both at the gene and protein level, were studied in vitro using cells derived from both genotypes.
Results: Deficiency of the plasminogen activators led to elongation of the bones and to increased bone mass (25% more trabecular bone in the proximal tibial metaphysis), without altering the morphology of the growth plate. In addition, the composition of bone matrix was modified in plasminogen activator deficient mice, because an increased amount of proteoglycans (2x), osteocalcin (+45%), and fibronectin (+36%) was detected. Matrix degradation assays showed that plasminogen activators, by generating plasmin, participate in osteoblast-mediated degradation of the noncollagenous components of bone matrix. In addition, proliferation of primary osteoblasts derived from plasminogen activator-deficient mice was increased by 35%. Finally, osteoblast differentiation and formation of a mineralized bone matrix were enhanced in osteoblast cultures derived from tPA-/-:uPA-/- mice.
Conclusions: The data presented indicate the importance of the plasminogen system in degradation of the noncollagenous components of bone matrix and suggest that the accumulation of these proteins in bone matrix--as occurs during plasminogen activator deficiency--may in turn stimulate osteoblast function, resulting in increased bone formation.
Similar articles
-
The role of the plasminogen system in bone resorption in vitro.J Bone Miner Res. 1999 Jun;14(6):946-52. doi: 10.1359/jbmr.1999.14.6.946. J Bone Miner Res. 1999. PMID: 10352103
-
Plasminogen activators are involved in the degradation of bone by osteoclasts.Bone. 2008 Nov;43(5):915-20. doi: 10.1016/j.bone.2008.07.004. Epub 2008 Jul 21. Bone. 2008. PMID: 18691680
-
Tissue-type plasminogen activator deficiency delays bone repair: roles of osteoblastic proliferation and vascular endothelial growth factor.Am J Physiol Endocrinol Metab. 2014 Aug 1;307(3):E278-88. doi: 10.1152/ajpendo.00129.2014. Epub 2014 Jun 10. Am J Physiol Endocrinol Metab. 2014. PMID: 24918201
-
Tissue plasminogen activator in psoriasis.J Invest Dermatol. 1990 Nov;95(5 Suppl):13S-14S. doi: 10.1111/1523-1747.ep12505666. J Invest Dermatol. 1990. PMID: 16788619 Review.
-
Plasticity-related serine proteases in the brain (review).Int J Mol Med. 1999 Apr;3(4):405-9. doi: 10.3892/ijmm.3.4.405. Int J Mol Med. 1999. PMID: 10085414 Review.
Cited by
-
Porphyromonas gingivalis-derived RgpA-Kgp Complex Activates the Macrophage Urokinase Plasminogen Activator System: IMPLICATIONS FOR PERIODONTITIS.J Biol Chem. 2015 Jun 26;290(26):16031-42. doi: 10.1074/jbc.M115.645572. Epub 2015 May 15. J Biol Chem. 2015. PMID: 25979345 Free PMC article.
-
Plasminogen activator inhibitor-1 is involved in streptozotocin-induced bone loss in female mice.Diabetes. 2013 Sep;62(9):3170-9. doi: 10.2337/db12-1552. Epub 2013 May 28. Diabetes. 2013. PMID: 23715621 Free PMC article.
-
u-PAR expression in cancer associated fibroblast: new acquisitions in multiple myeloma progression.BMC Cancer. 2017 Mar 24;17(1):215. doi: 10.1186/s12885-017-3183-y. BMC Cancer. 2017. PMID: 28340565 Free PMC article.
-
Urokinase plasminogen activator gene deficiency inhibits fracture cartilage remodeling.J Bone Miner Metab. 2014 Mar;32(2):124-35. doi: 10.1007/s00774-013-0475-4. Epub 2013 May 23. J Bone Miner Metab. 2014. PMID: 23700285
-
Plasmin is essential in preventing periodontitis in mice.Am J Pathol. 2011 Aug;179(2):819-28. doi: 10.1016/j.ajpath.2011.05.003. Epub 2011 Jun 2. Am J Pathol. 2011. PMID: 21704601 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous